Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
February 19, 2026 Off

Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

By BusinessWire

BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a…

February 19, 2026 Off

Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery

By BusinessWire

New chemistry reduces barriers to scaling single-cell studies across research settings Launch planned for March 2026, available across Evercode Whole…

February 19, 2026 Off

WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

By BusinessWire

WELL and HEALWELL launch WELLTRUST™, a consent-first data governance and patient-identification platform enabling secure, compliant and scalable clinics data mobilization…

February 19, 2026 Off

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026

By BusinessWire

PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions…

February 19, 2026 Off

YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency

By BusinessWire

Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of…

February 19, 2026 Off

VivaMed BioPharma Partners With Syngene International to Advance AI-Derived Repurposed Therapeutic Programs Through Global Validation Infrastructure

By BusinessWire

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#ai–VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved…

February 19, 2026 Off

Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons

By BusinessWire

Second season results from the Phase 3 SMART trial were presented at the 9th RSVVW Conference and will be shared…

February 19, 2026 Off

FNIH Biomarkers Consortium Study Shows “Clock Model” Blood Test Can Predict Onset of Alzheimer’s Symptoms Years in Advance

By BusinessWire

The “clock model” can use a single blood test to estimate the onset of symptoms within 3-4 years. A new…

February 19, 2026 Off

SEQSTER Launches 1-Click Data Refinery™ to Power Scalable AI Across Clinical Trials

By BusinessWire

Enterprise-ready harmonization engine delivers AI-ready clinical data for faster cohort discovery, trial screening, feasibility analysis, and ongoing study execution. SAN…

February 19, 2026 Off

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026

By BusinessWire

LYON, France–(BUSINESS WIRE)–#Biotech–Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for…

Posts pagination

Previous 1 2 3 4 … 6,330 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 19, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine